Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

September 13, 2020

The Critical Path Institute: 15 Years of Impact

A catalyst in the development of new tools and approaches to advance regulatory science and medical product developm

C-Path Awarded FDA Drug Development Tool Research Grant to Develop a Qualification Plan for the PROMIS® Short Form v2.1—Physical Function-Multiple Sclerosis 15a (PROMIS PFMS—15a)

C-Path’s Patient-Reported Outcome (PRO) Consortium announced today it has been awarded a U.S. Food and Drug Administratio

August 25, 2020

Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions

C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...

C-Path’s PKDOC and The PKD Foundation Set to Collaborate Once Again

Polycystic Kidney Disease (PKD) is an inherited disorder in which clusters of cysts develop in the kidneys. There are more than 20

August 16, 2020

Remote Digital Monitoring for Medical Product Development

Izmailova ES, Wagner JA, Ammour N, Amondikar N, Bell‐Vlasov A, Berman S, Bloomfield D, Brady LS, Cai X, Calle RA, Campbell M...

August 14, 2020

Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?

ePRO Consortium Announces Publication of Open Access Article

C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics

October 19, 2020

Watch Now: RDCA-DAP 2020 Virtual Workshop

Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about: RDCA-D

August 11, 2020

Neonatal Adverse Events Severity Scale on NIH website

August 11, 2020

Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019

Previous4546 47...109 Next